Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries.


Journal

The lancet. Psychiatry
ISSN: 2215-0374
Titre abrégé: Lancet Psychiatry
Pays: England
ID NLM: 101638123

Informations de publication

Date de publication:
07 2021
Historique:
received: 22 12 2020
revised: 12 02 2021
accepted: 24 02 2021
pubmed: 17 4 2021
medline: 29 6 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

The COVID-19 pandemic is having profound mental health consequences for many people. Concerns have been expressed that, at their most extreme, these consequences could manifest as increased suicide rates. We aimed to assess the early effect of the COVID-19 pandemic on suicide rates around the world. We sourced real-time suicide data from countries or areas within countries through a systematic internet search and recourse to our networks and the published literature. Between Sept 1 and Nov 1, 2020, we searched the official websites of these countries' ministries of health, police agencies, and government-run statistics agencies or equivalents, using the translated search terms "suicide" and "cause of death", before broadening the search in an attempt to identify data through other public sources. Data were included from a given country or area if they came from an official government source and were available at a monthly level from at least Jan 1, 2019, to July 31, 2020. Our internet searches were restricted to countries with more than 3 million residents for pragmatic reasons, but we relaxed this rule for countries identified through the literature and our networks. Areas within countries could also be included with populations of less than 3 million. We used an interrupted time-series analysis to model the trend in monthly suicides before COVID-19 (from at least Jan 1, 2019, to March 31, 2020) in each country or area within a country, comparing the expected number of suicides derived from the model with the observed number of suicides in the early months of the pandemic (from April 1 to July 31, 2020, in the primary analysis). We sourced data from 21 countries (16 high-income and five upper-middle-income countries), including whole-country data in ten countries and data for various areas in 11 countries). Rate ratios (RRs) and 95% CIs based on the observed versus expected numbers of suicides showed no evidence of a significant increase in risk of suicide since the pandemic began in any country or area. There was statistical evidence of a decrease in suicide compared with the expected number in 12 countries or areas: New South Wales, Australia (RR 0·81 [95% CI 0·72-0·91]); Alberta, Canada (0·80 [0·68-0·93]); British Columbia, Canada (0·76 [0·66-0·87]); Chile (0·85 [0·78-0·94]); Leipzig, Germany (0·49 [0·32-0·74]); Japan (0·94 [0·91-0·96]); New Zealand (0·79 [0·68-0·91]); South Korea (0·94 [0·92-0·97]); California, USA (0·90 [0·85-0·95]); Illinois (Cook County), USA (0·79 [0·67-0·93]); Texas (four counties), USA (0·82 [0·68-0·98]); and Ecuador (0·74 [0·67-0·82]). This is the first study to examine suicides occurring in the context of the COVID-19 pandemic in multiple countries. In high-income and upper-middle-income countries, suicide numbers have remained largely unchanged or declined in the early months of the pandemic compared with the expected levels based on the pre-pandemic period. We need to remain vigilant and be poised to respond if the situation changes as the longer-term mental health and economic effects of the pandemic unfold. None.

Sections du résumé

BACKGROUND
The COVID-19 pandemic is having profound mental health consequences for many people. Concerns have been expressed that, at their most extreme, these consequences could manifest as increased suicide rates. We aimed to assess the early effect of the COVID-19 pandemic on suicide rates around the world.
METHODS
We sourced real-time suicide data from countries or areas within countries through a systematic internet search and recourse to our networks and the published literature. Between Sept 1 and Nov 1, 2020, we searched the official websites of these countries' ministries of health, police agencies, and government-run statistics agencies or equivalents, using the translated search terms "suicide" and "cause of death", before broadening the search in an attempt to identify data through other public sources. Data were included from a given country or area if they came from an official government source and were available at a monthly level from at least Jan 1, 2019, to July 31, 2020. Our internet searches were restricted to countries with more than 3 million residents for pragmatic reasons, but we relaxed this rule for countries identified through the literature and our networks. Areas within countries could also be included with populations of less than 3 million. We used an interrupted time-series analysis to model the trend in monthly suicides before COVID-19 (from at least Jan 1, 2019, to March 31, 2020) in each country or area within a country, comparing the expected number of suicides derived from the model with the observed number of suicides in the early months of the pandemic (from April 1 to July 31, 2020, in the primary analysis).
FINDINGS
We sourced data from 21 countries (16 high-income and five upper-middle-income countries), including whole-country data in ten countries and data for various areas in 11 countries). Rate ratios (RRs) and 95% CIs based on the observed versus expected numbers of suicides showed no evidence of a significant increase in risk of suicide since the pandemic began in any country or area. There was statistical evidence of a decrease in suicide compared with the expected number in 12 countries or areas: New South Wales, Australia (RR 0·81 [95% CI 0·72-0·91]); Alberta, Canada (0·80 [0·68-0·93]); British Columbia, Canada (0·76 [0·66-0·87]); Chile (0·85 [0·78-0·94]); Leipzig, Germany (0·49 [0·32-0·74]); Japan (0·94 [0·91-0·96]); New Zealand (0·79 [0·68-0·91]); South Korea (0·94 [0·92-0·97]); California, USA (0·90 [0·85-0·95]); Illinois (Cook County), USA (0·79 [0·67-0·93]); Texas (four counties), USA (0·82 [0·68-0·98]); and Ecuador (0·74 [0·67-0·82]).
INTERPRETATION
This is the first study to examine suicides occurring in the context of the COVID-19 pandemic in multiple countries. In high-income and upper-middle-income countries, suicide numbers have remained largely unchanged or declined in the early months of the pandemic compared with the expected levels based on the pre-pandemic period. We need to remain vigilant and be poised to respond if the situation changes as the longer-term mental health and economic effects of the pandemic unfold.
FUNDING
None.

Identifiants

pubmed: 33862016
pii: S2215-0366(21)00091-2
doi: 10.1016/S2215-0366(21)00091-2
pmc: PMC9188435
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

579-588

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MC_PC_17211
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : ErratumIn
Type : CommentIn
Type : ErratumIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Références

Int J Soc Psychiatry. 2021 Aug;67(5):606-608
pubmed: 32985316
Lancet Psychiatry. 2020 Jun;7(6):468-471
pubmed: 32330430
Psychiatry Res. 2021 Jan;295:113623
pubmed: 33307386
JAMA Netw Open. 2021 Jan 4;4(1):e2034273
pubmed: 33475750
Epidemiol Psychiatr Sci. 2021 Jan 19;30:e16
pubmed: 33461639
Lancet. 2016 Dec 10;388(10062):e19-e23
pubmed: 27371184
Acta Psychiatr Scand. 2021 Jan;143(1):92-93
pubmed: 33111325
Prev Med. 2020 Dec;141:106264
pubmed: 33017599
Psychiatry Res. 2021 Jan;295:113632
pubmed: 33338860
Psychiatry Res. 2021 Jan;295:113629
pubmed: 33290944
Nat Hum Behav. 2021 Feb;5(2):229-238
pubmed: 33452498
Child Abuse Negl. 2020 Dec;110(Pt 2):104680
pubmed: 32847679
Lancet Reg Health Eur. 2021 Apr 20;4:100110
pubmed: 34557817
Int J Soc Psychiatry. 2020 Dec;66(8):748-755
pubmed: 32650687
BMJ. 2013 Sep 17;347:f5239
pubmed: 24046155
Am J Forensic Med Pathol. 2021 Mar 1;42(1):99-100
pubmed: 33181519
Lancet Psychiatry. 2021 Jan;8(1):58-63
pubmed: 33212023
J Public Health (Oxf). 2021 Apr 13;:
pubmed: 33855451
Prev Med. 2021 Feb;143:106331
pubmed: 33232687
World Psychiatry. 2020 Oct;19(3):294-306
pubmed: 32931107
Crisis. 2021 Nov;42(6):474-487
pubmed: 33063542
F1000Res. 2020 Sep 4;9:1097
pubmed: 33604025
Psychiatry Res. 2021 Jan;295:113599
pubmed: 33285346
Lancet Psychiatry. 2021 Jan;8(1):15-17
pubmed: 33160581

Auteurs

Jane Pirkis (J)

Centre for Mental Health, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia. Electronic address: j.pirkis@unimelb.edu.au.

Ann John (A)

Swansea University Medical School, Swansea, UK.

Sangsoo Shin (S)

Centre for Mental Health, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.

Marcos DelPozo-Banos (M)

Swansea University Medical School, Swansea, UK.

Vikas Arya (V)

Centre for Mental Health, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Translational Health Research Institute, Western Sydney University, Campbelltown, NSW, Australia.

Pablo Analuisa-Aguilar (P)

Ministry of Public Health, Department of Health Promotion, Quito, Ecuador.

Louis Appleby (L)

National Confidential Inquiry into Suicide and Safety in Mental Health, University of Manchester, Manchester, UK.

Ella Arensman (E)

School of Public Health, National Suicide Research Foundation, University College Cork, Cork, Ireland; Australian Institute for Suicide Research and Prevention, School of Applied Psychology, Griffith University, Brisbane, QLD, Australia.

Jason Bantjes (J)

Institute for Life Course Health Research, Department of Global Health, Stellenbosch University, Stellenbosch, South Africa.

Anna Baran (A)

Working Group on Prevention of Suicide and Depression at Public Health Council, Warsaw, Poland; Department of Psychiatry, Blekinge Hospital, Karlshamn, Sweden.

Jose M Bertolote (JM)

Botucatu Medical School, Universidade Estadual Paulista, São Paulo, Brazil.

Guilherme Borges (G)

Instituto Nacional de Psiquiatría Ramon de la Fuente Muñiz, Mexico City, Mexico.

Petrana Brečić (P)

Department for Medical Ethics, University Psychiatric Hospital Vrapče, School of Medicine, University of Zagreb, Zagreb, Croatia; Department for Psychiatry, University Psychiatric Hospital Vrapče, School of Medicine, University of Zagreb, Zagreb, Croatia.

Eric Caine (E)

University of Rochester Medical Center, Rochester, NY, USA.

Giulio Castelpietra (G)

Region Friuli Venezia Giulia, Central Health Directorate, Outpatient and Inpatient Care Service, Trieste, Italy; Department of Medicine, University of Udine, Trieste, Italy.

Shu-Sen Chang (SS)

Institute of Health Behaviors and Community Sciences, College of Public Health, National Taiwan University, Taipei, Taiwan.

David Colchester (D)

Thames Valley Local Criminal Justice Board, Bicester, UK.

David Crompton (D)

Australian Institute for Suicide Research and Prevention, School of Applied Psychology, Griffith University, Brisbane, QLD, Australia.

Marko Curkovic (M)

Department for Medical Ethics, University Psychiatric Hospital Vrapče, School of Medicine, University of Zagreb, Zagreb, Croatia.

Eberhard A Deisenhammer (EA)

Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University of Innsbruck, Innsbruck, Austria.

Chengan Du (C)

Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, CT, USA.

Jeremy Dwyer (J)

Centre for Mental Health, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Coroners Court of Victoria, Melbourne, VIC, Australia.

Annette Erlangsen (A)

Danish Research Institute for Suicide Prevention, Copenhagen, Denmark; Department of Mental Health, Johns Hopkins School of Public Health, Baltimore, MD, USA; Centre for Mental Health Research, Australian National University, Canberra, ACT, Australia.

Jeremy S Faust (JS)

Brigham and Women's Hospital Department of Emergency Medicine, Boston, MA, USA.

Sarah Fortune (S)

School of Population Health, University of Auckland, Auckland, New Zealand.

Andrew Garrett (A)

Magistrates Court of Tasmania (Coronial Division), Hobart, TAS, Australia.

Devin George (D)

Bureau of Vital Records and Statistics, Louisiana Office of Public Health, Baton Rouge, LA, USA.

Rebekka Gerstner (R)

Ministry of Public Health, Undersecretary of Health Services, Quito, Ecuador.

Renske Gilissen (R)

Research Department, 113 Suicide Prevention, Amsterdam, Netherlands.

Madelyn Gould (M)

Departments of Psychiatry and Epidemiology, Columbia University Medical Center/New York State Psychiatric Institute, New York, NY, USA.

Keith Hawton (K)

Centre for Suicide Research, University of Oxford, Oxford, UK.

Joseph Kanter (J)

Louisiana Department of Health, Baton Rouge, LA, USA.

Navneet Kapur (N)

Centre for Mental Health and Safety and National Institute for Health Research Patient Safety Translational Research Centre, University of Manchester, Manchester, UK; Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Murad Khan (M)

Department of Psychiatry, Aga Khan University, Karachi, Pakistan.

Olivia J Kirtley (OJ)

KU Leuven, Center for Contextual Psychiatry, Leuven, Belgium.

Duleeka Knipe (D)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.

Kairi Kolves (K)

Australian Institute for Suicide Research and Prevention, School of Applied Psychology, Griffith University, Brisbane, QLD, Australia.

Stuart Leske (S)

Australian Institute for Suicide Research and Prevention, School of Applied Psychology, Griffith University, Brisbane, QLD, Australia.

Kedar Marahatta (K)

World Health Organization, Country Office for Nepal, Kathmandu, Nepal.

Ellenor Mittendorfer-Rutz (E)

Karolinska Institutet, Stockholm, Sweden.

Nikolay Neznanov (N)

Bekhterev National Medical Research Center of Psychiatry and Neurology, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia.

Thomas Niederkrotenthaler (T)

Unit Suicide Research and Mental Health Promotion, Department of Social and Preventive Medicine, Center for Public Health, Medical University of Vienna, Vienna, Austria.

Emma Nielsen (E)

School of Psychology, University of Nottingham, Nottingham, UK.

Merete Nordentoft (M)

Mental Health Centre Copenhagen, Copenhagen, Denmark.

Herwig Oberlerchner (H)

Department of Psychiatry and Psychotherapy, Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria.

Rory C O'Connor (RC)

Suicidal Behaviour Research Lab, University of Glasgow, Glasgow, UK.

Melissa Pearson (M)

Preventing Deaths from Poisoning Research Group, University of Edinburgh, Edinburgh, UK.

Michael R Phillips (MR)

Suicide Research and Prevention Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Departments of Psychiatry and Epidemiology, Columbia University, New York, NY, USA.

Steve Platt (S)

Usher Institute, University of Edinburgh, Edinburgh, UK.

Paul L Plener (PL)

Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria; Department of Child and Adolescent Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany.

Georg Psota (G)

Psychosocial Services in Vienna, Vienna, Austria.

Ping Qin (P)

National Centre for Suicide Research and Prevention, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Daniel Radeloff (D)

Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, University Hospital Leipzig, Leipzig, Germany.

Christa Rados (C)

Department of Psychiatry and Psychotherapeutic Medicine, Landeskrankenhaus Villach, Villach, Austria.

Andreas Reif (A)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany.

Christine Reif-Leonhard (C)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany.

Vsevolod Rozanov (V)

Department of Borderline Disorders and Psychotherapy, Bekhterev National Medical Research Center of Psychiatry and Neurology, Saint Petersburg State University, Saint Petersburg, Russia.

Christiane Schlang (C)

Department of Psychiatry, Health Authority Frankfurt am Main, Frankfurt, Germany.

Barbara Schneider (B)

Department of Addictive Disorders, Psychiatry and Psychotherapy, LVR-Klinik Köln, Cologne, Germany; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe-University, Frankfurt am Main, Germany.

Natalia Semenova (N)

Organizational-Scientific Department, Bekhterev National Medical Research Center of Psychiatry and Neurology, Saint Petersburg, Russia.

Mark Sinyor (M)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Ellen Townsend (E)

Self-Harm Research Group, School of Psychology, University of Nottingham, Nottingham, UK.

Michiko Ueda (M)

Waseda University, Faculty of Political Science and Economics, Tokyo, Japan.

Lakshmi Vijayakumar (L)

Sneha-Suicide Prevention Centre, Voluntary Health Services, Chennai, India.

Roger T Webb (RT)

Centre for Mental Health and Safety and National Institute for Health Research Patient Safety Translational Research Centre, University of Manchester, Manchester, UK.

Manjula Weerasinghe (M)

Department of Community Medicine, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Anuradhapura, Sri Lanka.

Gil Zalsman (G)

Department of Psychiatry, Sackler School of Medicine, Tel Aviv University and Geha Mental Health Center, Tel Aviv, Israel; Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York, USA.

David Gunnell (D)

National Institute of Health Research Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust, University of Bristol, Bristol, UK.

Matthew J Spittal (MJ)

Centre for Mental Health, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH